Mindaugas Jievaltas

2.2k total citations · 1 hit paper
65 papers, 1.3k citations indexed

About

Mindaugas Jievaltas is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Oncology. According to data from OpenAlex, Mindaugas Jievaltas has authored 65 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Pulmonary and Respiratory Medicine, 15 papers in Rheumatology and 13 papers in Oncology. Recurrent topics in Mindaugas Jievaltas's work include Prostate Cancer Diagnosis and Treatment (31 papers), Prostate Cancer Treatment and Research (29 papers) and Urinary Bladder and Prostate Research (9 papers). Mindaugas Jievaltas is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (31 papers), Prostate Cancer Treatment and Research (29 papers) and Urinary Bladder and Prostate Research (9 papers). Mindaugas Jievaltas collaborates with scholars based in Lithuania, United States and Finland. Mindaugas Jievaltas's co-authors include Albertas Ulys, Karim Fizazi, Toni Sarapohja, Neal D. Shore, Egils Vjaters, Murilo Luz, Amir Snapir, S. Polyakov, Teuvo L.J. Tammela and B. Yа. Alekseev and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Mindaugas Jievaltas

60 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer

2019 579 citations Karim Fizazi, Neal D. Shore et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mindaugas Jievaltas Lithuania	14	1.0k	304	284	217	181	65	1.3k
Sabine Brookman‐May Germany	19	1.1k 1.1×	361 1.2×	357 1.3×	327 1.5×	243 1.3×	125	1.7k
Thomas Morris United Kingdom	23	1.1k 1.1×	235 0.8×	227 0.8×	338 1.6×	215 1.2×	59	1.6k
Tony Crispino United States	11	1.5k 1.5×	235 0.8×	267 0.9×	321 1.5×	128 0.7×	16	1.7k
Albertas Ulys Lithuania	16	1.1k 1.1×	459 1.5×	337 1.2×	323 1.5×	282 1.6×	64	1.4k
Giles Hellawell United Kingdom	17	476 0.5×	216 0.7×	223 0.8×	262 1.2×	377 2.1×	36	1.2k
Brian F. Chapin United States	22	1.5k 1.5×	349 1.1×	304 1.1×	406 1.9×	345 1.9×	116	1.9k
Anthony L. Patterson United States	23	1.2k 1.2×	200 0.7×	121 0.4×	213 1.0×	530 2.9×	44	1.6k
David S. Lamb New Zealand	15	1.4k 1.4×	156 0.5×	160 0.6×	232 1.1×	83 0.5×	40	1.6k
Michiyuki Usami Japan	21	962 1.0×	163 0.5×	110 0.4×	187 0.9×	268 1.5×	89	1.3k
Lionel L. Bañez United States	26	1.4k 1.4×	477 1.6×	105 0.4×	525 2.4×	484 2.7×	75	2.1k

Countries citing papers authored by Mindaugas Jievaltas

Since Specialization

Citations

This map shows the geographic impact of Mindaugas Jievaltas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mindaugas Jievaltas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mindaugas Jievaltas more than expected).

Fields of papers citing papers by Mindaugas Jievaltas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mindaugas Jievaltas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mindaugas Jievaltas. The network helps show where Mindaugas Jievaltas may publish in the future.

Co-authorship network of co-authors of Mindaugas Jievaltas

This figure shows the co-authorship network connecting the top 25 collaborators of Mindaugas Jievaltas. A scholar is included among the top collaborators of Mindaugas Jievaltas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mindaugas Jievaltas. Mindaugas Jievaltas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jievaltas, Mindaugas, et al.. (2024). Primary Renal Angiosarcoma: Rare Tumour with Lethal Outcomes. Medicina. 60(6). 885–885.

Basevičius, Algidas, et al.. (2023). Prostatic Artery Embolization as a Treatment Option for Symptomatic Benign Prostatic Hyperplasia: Results from the Prospective Follow-Up Study in Lithuania. Medicina. 59(10). 1871–1871. 3 indexed citations

Patašius, Aušvydas, et al.. (2023). Incidence, mortality and survival trends of penile cancer in Lithuania 1998–2017. Frontiers in Oncology. 13. 1124101–1124101. 1 indexed citations

Bögemann, Martin, Neal D. Shore, Matthew R. Smith, et al.. (2022). Efficacy and Safety of Darolutamide in Patients with Nonmetastatic Castration-resistant Prostate Cancer Stratified by Prostate-specific Antigen Doubling Time: Planned Subgroup Analysis of the Phase 3 ARAMIS Trial. European Urology. 83(3). 212–221. 7 indexed citations

Muilwijk, Tim, et al.. (2021). Head-to-Head Comparison of Two Nomograms Predicting Probability of Lymph Node Invasion in Prostate Cancer and the Therapeutic Impact of Higher Nomogram Threshold. Journal of Clinical Medicine. 10(5). 999–999. 9 indexed citations

Klotz, Laurence, N. Axén, Cecilia Wassberg, et al.. (2021). Liproca Depot: A New Antiandrogen Treatment for Active Surveillance Patients. European Urology Focus. 8(1). 112–120. 3 indexed citations

Fizazi, Karim, Neal D. Shore, Teuvo L.J. Tammela, et al.. (2020). 223P Overall survival (OS) results of phase III ARAMIS study of darolutamide (DARO) added to androgen deprivation therapy (ADT) for non-metastatic castration-resistant prostate cancer (nmCRPC). Annals of Oncology. 31. S1328–S1328. 2 indexed citations

Patašius, Aušvydas, et al.. (2019). A Population-Based Analysis of Incidence, Mortality, and Survival in Testicular Cancer Patients in Lithuania. Medicina. 55(9). 552–552. 6 indexed citations

Jievaltas, Mindaugas, et al.. (2019). Significance of Time Until PSA Recurrence After Radical Prostatectomy Without Neo- or Adjuvant Treatment to Clinical Progression and Cancer-Related Death in High-Risk Prostate Cancer Patients. Frontiers in Oncology. 9. 1286–1286. 21 indexed citations

10.

Milonas, Daimantas, et al.. (2019). Impact of the 2014 International Society of Urological Pathology Grading System on Concept of High-Risk Prostate Cancer: Comparison of Long-Term Oncological Outcomes in Patients Undergoing Radical Prostatectomy. Frontiers in Oncology. 9. 1272–1272. 7 indexed citations

11.

Shore, Neal D., Vladimír Študent, Mindaugas Jievaltas, et al.. (2019). A phase 3, open-label, multicenter study of a 6-month pre-mixed depot formulation of leuprolide mesylate in advanced prostate cancer patients. World Journal of Urology. 38(1). 111–119. 9 indexed citations

12.

Trumbeckaitė, Sonata, et al.. (2017). Caffeic Acid Phenethyl Ester Reduces Ischemia‐Induced Kidney Mitochondrial Injury in Rats. Oxidative Medicine and Cellular Longevity. 2017(1). 1697018–1697018. 19 indexed citations

13.

Kinčius, Marius, et al.. (2016). Evaluation of LRINEC Scale Feasibility for Predicting Outcomes of Fournier Gangrene. Surgical Infections. 17(4). 448–453. 32 indexed citations

14.

Banienė, Rasa, Marius Kinčius, Neringa Paužienė, et al.. (2016). Short ischemia induces rat kidney mitochondria dysfunction. Journal of Bioenergetics and Biomembranes. 48(1). 77–85. 14 indexed citations

15.

Milonas, Daimantas, et al.. (2016). Dutasteride for the prevention of prostate cancer in men with high-grade prostatic intraepithelial neoplasia: results of a phase III randomized open-label 3-year trial. World Journal of Urology. 35(5). 721–728. 3 indexed citations

16.

Milonas, Daimantas, et al.. (2015). The effect of complete transurethral resection of the prostate on symptoms, quality of life, and voiding function improvement. Editor-in-Chief s Voice List of Authors is an Important Element in a Scientific Publication. 68(2). 169–74. 10 indexed citations

17.

Kinčius, Marius, et al.. (2011). Independent predictors of biochemical recurrence after radical prostatectomy: a single center experience. Editor-in-Chief s Voice List of Authors is an Important Element in a Scientific Publication. 64(1). 21–25. 6 indexed citations

18.

Milonas, Daimantas, et al.. (2011). Outcome of surgery in locally advanced pT3a prostate cancer. Editor-in-Chief s Voice List of Authors is an Important Element in a Scientific Publication. 64(4). 209–212. 7 indexed citations

19.

Milonas, Daimantas, et al.. (2011). UROLOGICAL ONCOLOGY Factors predicting Gleason score 6 upgrading after radical prostatectomy. Editor-in-Chief s Voice List of Authors is an Important Element in a Scientific Publication. 64(4). 205–208. 10 indexed citations

20.

Milonas, Daimantas, et al.. (2006). Influence of catheter on urinary flow during urodynamic pressure-flow study in men with symptomatic benign prostatic hyperplasia.. PubMed. 42(1). 15–21. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact